Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (151-160 of 400) with videos related to

Pageof 40
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2022
CXCR4-targeted theranostics in oncologyAndreas K Buck, Sebastian E Serfling, Thomas Lindner, et al.
Cancers|September 10, 2021
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [<sup>177</sup>Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient OutcomePhilipp E Hartrampf, Constantin Lapa, Sebastian E Serfling, et al.
Endocrine|December 22, 2023
[<sup>18</sup>F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patientsYingjun Zhi, Takahiro Higuchi, Stephan Hackenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Theranostics in HematooncologyAndreas K Buck, Sebastian E Serfling, Sabrina Kraus, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2003
F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient managementMartin Hetzel, Coskun Arslandemir, Hans-Helmut König, et al.
Clinical Nuclear Medicine|April 19, 2022
Rechallenge With Additional Doses of 177 Lu-DOTATOC After Failure of Maintenance Therapy With Cold Somatostatin AnalogsAlexander Weich, Rudolf A Werner, Sebastian E Serfling, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.
Oncotarget|March 4, 2016
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapyConstantin Lapa, Heribert Hänscheid, Vanessa Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancerH Schirrmeister, G Glatting, J Hetzel, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinomaStefanie Hahner, Michael C Kreissl, Martin Fassnacht, et al.
Pageof 40

Showing results (151-160 of 400) with videos related to

Sort By:
Pageof 40
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2022
CXCR4-targeted theranostics in oncologyAndreas K Buck, Sebastian E Serfling, Thomas Lindner, et al.
Cancers|September 10, 2021
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [<sup>177</sup>Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient OutcomePhilipp E Hartrampf, Constantin Lapa, Sebastian E Serfling, et al.
Endocrine|December 22, 2023
[<sup>18</sup>F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patientsYingjun Zhi, Takahiro Higuchi, Stephan Hackenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Theranostics in HematooncologyAndreas K Buck, Sebastian E Serfling, Sabrina Kraus, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2003
F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient managementMartin Hetzel, Coskun Arslandemir, Hans-Helmut König, et al.
Clinical Nuclear Medicine|April 19, 2022
Rechallenge With Additional Doses of 177 Lu-DOTATOC After Failure of Maintenance Therapy With Cold Somatostatin AnalogsAlexander Weich, Rudolf A Werner, Sebastian E Serfling, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.
Oncotarget|March 4, 2016
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapyConstantin Lapa, Heribert Hänscheid, Vanessa Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancerH Schirrmeister, G Glatting, J Hetzel, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinomaStefanie Hahner, Michael C Kreissl, Martin Fassnacht, et al.
Pageof 40